Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

Vaccine Issues Author: Staff Editor Last Updated: Jul 2, 2014 - 8:08:19 AM



International Vaccine Institute Launches New Video Marketing Campaign, 'Choose Your World'

By Staff Editor
Jul 2, 2014 - 8:02:52 AM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page

(HealthNewsDigest.com) - SEOUL, South Korea, July 2, 2014  -- The International Vaccine Institute (IVI) unveiled today a new integrated video marketing campaign, "Choose Your World," promoting awareness and encouraging grassroots fundraising to support the organization's initiatives. The campaign features a 3-minute video and a microsite (choose.ivi.int) that provides a snapshot of IVI and its work to combat deadly infectious diseases, as well as a link for people to support IVI through online donation. It is the first global marketing campaign of its kind launched by the international organization devoted to new and improved vaccines for the world's poor.

The video animates IVI's mission by depicting the life cycle of a small gift made to IVI. The donor watches their dollars fund cutting-edge research, the development and vetting of new vaccines, and successful vaccine delivery to at-risk populations around the world. The video empowers the donor, and inspires potential donors to make a contribution to IVI's public health and research initiatives.

"We wanted to clearly depict how much a small donation can do for the citizens of the world who suffer from conditions that can be easily prevented with vaccines," said Dr. Thomas F. Wierzba, Deputy Director General of Vaccine Development & Delivery at IVI. "We believe that the campaign has effectively captured the significance of the work we do, and we look forward to sharing our vision with the world."

IVI is an independent nonprofit international organization headquartered in Seoul, South Korea. The organization's mission is to discover, develop, and deliver safe, effective, and affordable vaccines for developing nations. Working in collaboration with the international scientific community, public health organizations, governments and industry, IVI is involved in all areas of the vaccine spectrum - from new vaccine discovery and design in the laboratory to vaccine development as well as evaluation in the field to facilitating sustainable introduction of vaccines in countries where they are most needed. IVI currently focuses on three primary diseases including cholera, enteric fever (typhoid) and dengue fever.

One of IVI's most significant, groundbreaking contributions is the development and licensure of an oral cholera vaccine, Shanchol(TM), which is World Health Organization (WHO) approved. A clinical study published in the Lancet Infectious Diseases in October 2013 shows long-term protection given by this affordable vaccine compared to other cholera vaccines.

IVI's broad-spectrum marketing approach includes traditional and online media outreach in conjunction with a robust social media engagement campaign on Twitter, Facebook and YouTube.

About IVI

The International Vaccine Institute (IVI) is the world's only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world's poorest people, especially children in developing countries. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization. The Institute conducts research in more than 20 countries of Asia, Africa and Latin America on vaccines against enteric and diarrheal infections, Japanese encephalitis, and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea. For more information, please visit www.ivi.int.

Web Site: http://www.ivi.int

###
For rates and information on advertising, call Mike McCurdy at 877-634-9180. Or email at [email protected]  We have over 7,000 journalists as subscribers.



Top of Page

HealthNewsDigest.com

Vaccine Issues
Latest Headlines


+ Vaccine Against Tick-transmitted Disease
+ Novartis Begins Shipment of Seasonal Influenza Vaccines to US Market for the 2014-2015 Season
+ Personalized Brain Tumor Vaccine Helps Patients Live Longer
+ International Vaccine Institute Launches New Video Marketing Campaign, 'Choose Your World'
+ AHRQ Report Provides Important Reassurances About the Safety of Commonly Used Vaccines
+ When Hospital Workers Get Vaccines, Community Flu Rates Fall
+ Flu Vaccine Reduced Children’s Risk of Intensive Care Unit Flu Admission by Three-Fourths
+ 8 in 10 Adolescent Girls in the Americas Have Access to HPV Vaccine, Following its Introduction in Brazil
+ Growth and Improvement in Pharmacy-based Immunizations
+ Vaccines: A Critical Tool in Protecting and Promoting Public Health



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions